(Stroke. 1995;26:1369-1372.)
© 1995 American Heart Association, Inc.
Articles |
Hyperbaric Oxygen in the Treatment of Acute Ischemic Stroke
A Double-blind Pilot Study
From the Department of Neurology, Cerebrovascular Disease and Ataxia Research Center (N.N., P.T.), and Department of Anesthesiology (F.S.), Neurological Hospital, and Laboratoire d'Informatique Médicale, UFR Alexis Carrel (P.A.), Lyon, France.
Correspondence to Dr N. Nighoghossian, Service de Neurologie du Pr Trouillas (Urgences Neurovasculaires et Centre de Recherches sur l'Ataxie), Hôpital Neurologique, 59 Bd Pinel, Lyon 69003, France.
Background and Purpose The effects of hyperbaric oxygen (HBO) therapy on humans are uncertain. Our study aims first to outline the practical aspects and the safety of HBO treatment and then to evaluate the effect of HBO on long-term disability.
Methods Patients who experienced middle cerebral artery occlusion and were seen within 24 hours of onset were randomized to receive either active (HBO) or sham (air) treatment. The HBO patients were exposed daily to 40 minutes at 1.5 atmospheres absolute for a total of 10 dives. We used the Orgogozo scale to establish a pretreatment functional level. Changes in the Orgogozo scale score at 6 months and 1 year after therapy were used to assess the therapeutic efficacy of HBO. In addition, we used the Rankin scale and our own 10-point scale to assess long term-disability at 6 months and 1 year. Two sample t tests and 95% confidence intervals were used to compare the mean differences between the two treatment groups. Student's two-tailed test was used to compare the differences between pretherapeutic and posttherapeutic scores at 6 months and 1 year in the two treatment groups.
Results Over the 3 years of study enrollment, 34 patients were randomized, 17 to hyperbaric treatment with air and 17 to hyperbaric treatment with 100% oxygen. There was no significant difference at inclusion between groups regarding age, time from stroke onset to randomization, and Orgogozo scale scores.
Neurological deterioration occurred during the first week in 4 patients in the sham group, 3 of whom died; this worsening was clearly related to the ischemic damage. Treatment was also discontinued for 3 patients in the HBO group who experienced myocardial infarction, a worsening related to the ischemic process, and claustrophobia. Therefore, 27 patients (13 in the sham group and 14 in the HBO group) completed a full course of therapy.
The mean score of the HBO group was significantly better on the Orgogozo scale at 1 year (P<.02). However, the difference at 1 year between pretherapeutic and posttherapeutic scores was not significantly different in the two groups (P<.16). Moreover, no statistically significant improvement was observed in the HBO group at 6 months and 1 year according to Rankin score (P<.78) and our own 10-point scale (P<.50).
Conclusions Although the small number of patients in each group precludes any conclusion regarding the potential deleterious effect of HBO, we did not observe the major side effects usually related to HBO. Accordingly, it can be assumed that hyperbaric oxygen might be safe. We hypothesize that HBO might improve outcome after stroke, as we detected an outcome trend favoring HBO therapy. A large randomized trial might be required to address the efficacy of this therapy.
Key Words: hyperbaric oxygenation • outcome • oxygen • stroke management
This article has been cited by other articles:
 |
|
 |
|
  L. Sun, H. H. Marti, and R. Veltkamp Hyperbaric Oxygen Reduces Tissue Hypoxia and Hypoxia-Inducible Factor-1{alpha} Expression in Focal Cerebral Ischemia Stroke, March 1, 2008; 39(3): 1000 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, May 22, 2007; 115(20): e478 - e534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Stroke, May 1, 2007; 38(5): 1655 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bennett, J. Wasiak, C. French, P. Kranke, and A. Schnabel Response to Letter by Helms et al Stroke, April 1, 2007; 38(4): 1138 - 1139. [Full Text] [PDF]
|
|
|
|
|
|
A. K. Helms, H. T. Whelan, and M. T. Torbey Hyperbaric Oxygen Therapy of Acute Ischemic Stroke Stroke, April 1, 2007; 38(4): 1137 - 1137. [Full Text] [PDF]
|
|
|
|
 |
|
 K. P. Stoller Quantification of Neurocognitive Changes Before, During, and After Hyperbaric Oxygen Therapy in a Case of Fetal Alcohol Syndrome Pediatrics, October 1, 2005; 116(4): e586 - e591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Carson, M. McDonagh, B. Russman, and M. Helfand Hyperbaric oxygen therapy for stroke: a systematic review of the evidence Clinical Rehabilitation, August 1, 2005; 19(8): 819 - 833. [Abstract] [PDF]
|
|
|
|
|
|
A. B. Singhal, T. Benner, L. Roccatagliata, W. J. Koroshetz, P. W. Schaefer, E. H. Lo, F. S. Buonanno, R. G. Gonzalez, and A. G. Sorensen A Pilot Study of Normobaric Oxygen Therapy in Acute Ischemic Stroke Stroke, April 1, 2005; 36(4): 797 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.L. Gill and C.N.A. Bell Hyperbaric oxygen: its uses, mechanisms of action and outcomes QJM, July 1, 2004; 97(7): 385 - 395. [Full Text] [PDF]
|
|
|
|
|
|
J. H. Zhang, A. B. Singhal, and J. F. Toole Oxygen Therapy in Ischemic Stroke Stroke, September 1, 2003; 34 (9): e152 - e153. [Full Text] [PDF]
|
|
|
|
|
|
H. P. Adams Jr, R. J. Adams, T. Brott, G. J. del Zoppo, A. Furlan, L. B. Goldstein, R. L. Grubb, R. Higashida, C. Kidwell, T. G. Kwiatkowski, et al. Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association Stroke, April 1, 2003; 34(4): 1056 - 1083. [Full Text] [PDF]
|
|
|
|
|
|
D. E. Rusyniak, M. A. Kirk, J. D. May, L. W. Kao, E. J. Brizendine, J. L. Welch, W. H. Cordell, and R. J. Alonso Hyperbaric Oxygen Therapy in Acute Ischemic Stroke: Results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study Stroke, February 1, 2003; 34(2): 571 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Singhal, R. M. Dijkhuizen, B. R. Rosen, and E. H. Lo Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke Neurology, March 26, 2002; 58(6): 945 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Uchino, D. Billheimer, and S. C. Cramer Entry Criteria and Baseline Characteristics Predict Outcome in Acute Stroke Trials Stroke, April 1, 2001; 32(4): 909 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bhalla, C.D.A. Wolfe, and A.G. Rudd Management of acute physiological parameters after stroke QJM, March 1, 2001; 94(3): 167 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. M. Ronning and B. Guldvog Should Stroke Victims Routinely Receive Supplemental Oxygen? : A Quasi-Randomized Controlled Trial Stroke, October 1, 1999; 30(10): 2033 - 2037. [Abstract] [Full Text] [PDF]
|
|